Author: A-CAPP Center

  Counterfeit Pharmaceuticals: Examining the Multidimensional Risks to African Nations Read the Book Chapter Roy Fenoff and Jeremy Wilson, 2011   Described as the crime of the twenty-first century, counterfeit products threaten public health and safety, reduce jobs and tax bases, and inhibit corporate innovativeness and profitability. The production, distribution, and consumption of counterfeit pharmaceuticals […]

  Pharmaceutical Counterfeiting in the US: Differentiating Dimensions of the Risk Read the Full Article Justin Heinonen and Jeremy Wilson, 2011   The creation of a product counterfeiting database highlights variation in known incidents of counterfeit pharmaceuticals across several important dimensions.  By understanding how these incidents differ, researchers can provide empirical insights into the problem, […]

  Product Counterfeiting in Australia Read the Full Article John Spink, 2011   Australia faces the same product counterfeiting challenges as the rest of the world. The problem is extremely varied, quickly evolves, is often hard to detect, and provides great challenges in data gathering. Though much of the counterfeit products are manufactured in Asian […]

  The A-CAPPP Product Counterfeiting Incident Database: A Resource for Advancing Research and Policy Read the Full Article Jeremy Wilson and Justin Heinonen, 2011   The creation of a national product counterfeiting incident database allows researchers a unique opportunity to generate evidence-based anti-counterfeiting strategy through the analysis of data and evidence.  Integrating the tenets of […]

  The Health and Economic Effects of Counterfeit Pharmaceuticals in Africa Click here to read the full publication Jeremy Wilson and Roy Fenoff, 2011   Reports of counterfeit pharmaceuticals in Africa indicate a wide variety of detrimental effects.  In addition to those in public health, these include lost revenues to firms that might otherwise be […]